Effects of Rhodiola rosea L. extract on behavioural and physiological alterations induced by chronic mild stress in female rats

2008 ◽  
Vol 23 (2) ◽  
pp. 130-142 ◽  
Author(s):  
L Mattioli ◽  
C Funari ◽  
M Perfumi
2004 ◽  
Vol 179 (4) ◽  
pp. 769-780 ◽  
Author(s):  
Angela J. Grippo ◽  
Nicole R. Sullivan ◽  
Katerina J. Damjanoska ◽  
James W. Crane ◽  
Gonzalo A. Carrasco ◽  
...  

2019 ◽  
Vol 1723 ◽  
pp. 146402
Author(s):  
Guillermo A. Ariza Traslaviña ◽  
Fernanda Pedrosa Torres ◽  
Procópio Cleber Gama de Barcelos Filho ◽  
Fabiana Lucio-Oliveira ◽  
Celso Rodrigues Franci

Stress ◽  
2007 ◽  
Vol 10 (3) ◽  
pp. 283-293 ◽  
Author(s):  
S. Baker ◽  
C. Bielajew

2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1199-1199
Author(s):  
Jeong-Eun Choi ◽  
Yongsoon Park

Abstract Objectives The purpose of the present study was to investigate the hypothesis that lifetime n-3 polyunsaturated fatty acids (PUFA) intake improved depression through serotonergic pathway in post-menopausal rats with chronic mild stress (CMS) and maternal separation (MS). Methods Female rats were fed diets with 0% or 1 energy % n-3 PUFA during lifetime from embryonic day (ED) 0 to postnatal day (PND) 112, or 1% n-3 PUFA before weaning (ED 0-PND 20), or after weaning (PND 20–112). The rats in four diet group were allocated to brief separation from dam (non-MS group) or long-term separation (MS group) on PND 2–14, and then underwent CMS on PND 91–105 after ovariectomy. Thus, there were eight groups in total (n = 8/group). Results MS + CMS increased depressive behaviors, and modified hypothalamic-pituitary-adrenal (HPA) axis activity, inflammation, serotonergic and glutamatergic neurotransmission, and related miRNAs as compared to CMS alone. N-3 PUFA decreased depressive behaviors by decreasing immobility while increasing swimming during forced swim test, and increasing sucrose preference in rats with MS + CMS and with CMS. N-3 PUFA decreased HPA axis activity by modifying expressions of corticotrophin releasing factor and glucocorticoid receptor, and levels of adrenocorticotropic hormone and corticosterone. N-3 PUFA also reduced levels of TNF-α, IL-1β, IL-6, PGE2, and miRNA-218, and increased serotonergic neurotransmission, including expressions of cAMP response element binding protein, brain-derived neurotrophic factor and serotonin 1A receptor, and serotonin level, and expression of miRNA-155. In addition, lifetime supplementation of n-3 PUFA had greater effect than pre- or post-supplementation. N-3 PUFA had no effect on glutamatergic pathway including α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor and N-methyl-D-aspartate receptor. Conclusions The present study suggested that lifetime n-3 PUFA improved depression in post-menopausal rats with MS + CMS through modulation of serotonergic pathway by decreasing HPA axis activity but not glutamatergic pathway. Funding Sources This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2018R1A2B6002486).


Sign in / Sign up

Export Citation Format

Share Document